Bioengineering contributes to new advances against childhood cancer Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park, the INCLIVA Health Research Institute and the Hospital Clínico de Valencia have discovered how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. The study, published in Scientific Reports, opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments.

 

The Park collaborates on a project for mass COVID-19 testing service led by IBEC, IRB Barcelona and CNAG-CRG Blog Post

The Government of Catalonia has approved the creation of the Orfeu Programme with the aim of having new diagnostic tests for COVID-19, as a complement to the capacity of the health system. In an initial phase, there will be two mass testing sites: one at the Barcelona Science Park, jointly coordinated by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Research in Biomedicine (IRB Barcelona) and the Centro Nacional de Análisis Genómico (CNAG-CRG); and another coordinated by the Centre for Genomic Regulation (CRG) at its labs at the Barcelona Biomedical Research Park (PRBB).

 

Nostrum Biodiscovery appoints Ezequiel Mas as its new CEO and embarks on an ambitious expansion plan Blog Post

Nostrum Biodiscovery (NBD) has appointed Ezequiel Mas del Molino as its new CEO to lead a new phase of the company, which is establishing a leading position in the European market as a provider of cutting-edge bioinformatics technologies for drug design and discovery. NBD –a spin-off from the Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Supercomputing Centre (BSC-CNS), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA)– is located at the Barcelona Science Park and the North Campus of the Universitat Politècnica de Catalunya (UPC).

 

Nostrum Biodiscovery joins Barcelona Science Park Blog Post

Nostrum Biodiscovery, a spin-off created thanks to the transfer of technology from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), has moved to Barcelona Science Park. Combining its own technologies with the best modelling software on the market, the company provides in silico services to pharmaceutical and biotechnology companies to accelerate and optimise the design of therapeutic molecules and enzymes, and overcome the common “bottlenecks” in the most initial stages of drug discovery.

 

IBEC obtains a second accreditation as Severo Ochoa Centre of Excellence Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, is one of the six centres in Spain to be awarded accreditation in this round of the Severo Ochoa Excellence programme. Furthermore, IBEC is the only center that receives this accreditation for the second time. The awards last for four years and bring a million euros each year to the winning centres, it also implies strengthening research capacities and boosting success rates in other competitive funding programmes.

 

Núria Montserrat represents the European Research Council at the WEF Summer Davos in China Blog Post

Núria Montserrat, ICREA professor and principal investigator at the Institute for Bioengineering of Catalonia (IBEC) was among the nine scientists representatives of the European Research Council (ERC) at the Annual Meeting of the New Champions (AMNC), also known as “Summer Davos“. Organised by the World Economic Forum (WEF) in the Chinese city of Dailan from 1 to 3 July, the 2019 edition of this event brought together the brightest minds on the planet to discuss issues related to scientific research, leadership, and innovation.